Phase II study of a weekly liposomal paclitaxel formulation (Genexol®-PM) and gemcitabine® combination chemotherapy in patients with advanced biliary cancer.

被引：0
|
作者：
Uk, Keon Kean Uk [1 ]
Kim, Jin Young [1 ]
Do, Young Rok [1 ]
Song, Hong Suk [1 ]
Jeon, Young June [1 ]
Ryoo, Hun Mo [2 ]
Bae, Sung Hwa [2 ]
Kim, Jong Gwang [3 ]
Baek, Jin Ho [4 ]
Chae, Yee Soo [3 ]
Kim, Min Kyoung [5 ]
Lee, Kyung Hee [5 ]
Cho, Yoon Young [6 ]
机构：
[1] Keimyung Univ, Dongsan Med Ctr, Taegu, South Korea
[2] Daegu Catholic Univ Hosp, Taegu, South Korea
[3] Kyungpook Natl Univ Hosp, Taegu, South Korea
[4] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Ulsan 680749, South Korea
[5] Yeungnam Univ Hosp, Taegu, South Korea
[6] Dongguk Univ, Med Ctr, Gyeongju, South Korea
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-4659
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4659
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II study of paclitaxel in patients with advanced gastric cancer.
    Horikoshi, N
    Yamaguchi, K
    Otani, T
    Takiuchi, H
    Sakata, Y
    Taguchi, T
    ANNALS OF ONCOLOGY, 2000, 11 : 66 - 66
  • [22] A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
    Ahn, Hee Kyung
    Jung, Minkyu
    Sym, Sun Jin
    Shin, Dong Bok
    Kang, Shin Myung
    Kyung, Sun Young
    Park, Jeong-Woong
    Jeong, Sung Hwan
    Cho, Eun Kyung
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (02) : 277 - 282
  • [23] Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer
    Penz, M
    Kornek, GV
    Raderer, M
    Ulrich-Pur, H
    Fiebiger, W
    Lenauer, A
    Depisch, D
    Krauss, G
    Schneeweiss, B
    Scheithauer, W
    ANNALS OF ONCOLOGY, 2001, 12 (02) : 183 - 186
  • [24] Phase I study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer.
    Ueda, Y
    Yamagishi, H
    Ichikawa, D
    Koizumi, K
    Morii, J
    Takenaka, A
    Shimotsuma, M
    Kurioka, H
    Yamashita, T
    Sakamoto, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 368S - 368S
  • [25] A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer
    Lee, Jinsun
    Kim, Jeryong
    Chang, Eilsung
    Choi, Woonjung
    Lee, Kwangman
    Yoon, Hyunjo
    Jung, Sunghoo
    Park, Minho
    Yoon, Junghan
    Kim, Sungyong
    JOURNAL OF BREAST CANCER, 2014, 17 (04) : 344 - 349
  • [26] A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
    Hee Kyung Ahn
    Minkyu Jung
    Sun Jin Sym
    Dong Bok Shin
    Shin Myung Kang
    Sun Young Kyung
    Jeong-Woong Park
    Sung Hwan Jeong
    Eun Kyung Cho
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 277 - 282
  • [27] Phase II study of the combination chemotherapy with weekly carboplatin and gemcitabine in advanced non-small cell lung cancer
    Mori, K.
    Kamiyama, Y.
    Kasai, H.
    Kodama, T.
    EJC SUPPLEMENTS, 2009, 7 (02): : 524 - 524
  • [28] A Phase I/II trial of weekly gemcitabine with celecoxib and thalidomide for patients with advanced pancreatic cancer.
    Densmore, JJ
    Fox, JR
    Kannarkat, G
    Morgan, JK
    Petroni, G
    Blount, T
    Sullivan, K
    Williams, ME
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 367S - 367S
  • [29] A phase II study of weekly paclitaxel and doxifluridine (an intermediate metabolite of capecitabine) combination chemotherapy for advanced/recurrent gastric cancer
    Takeyoshi, I.
    Makita, F.
    Tanahashi, Y.
    Iwazaki, S.
    Nakamura, S.
    Ishikawa, H.
    Ogawa, T.
    Ohya, T.
    Kawate, S.
    Horiguchi, J.
    Morishita, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] A phase I/II study of antroquinonol in combination with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer.
    Shan, Yan-Shen
    Li, Chung-Pin
    Khan, Gazala
    Lee, Woo Jin
    Choi, Hye Jin
    Chang, Heung-Moon
    Lee, Moon Hee
    Wallmark, John M.
    Chen, Pei-Ni
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 648 - 648
12345